Nomura Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Nomura Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,727,400	Closed	-$211M	–	2164
2025 Q4	$211M	Buy	1,727,400 +1,165,600	+207%	+$134M	0.28%	43
2025 Q3	$56.3M	Buy	561,800 +24,300	+5%	+$2.19M	0.09%	144
2025 Q2	$44.6M	Buy	537,500 +425,000	+378%	+$33.9M	0.09%	144
2025 Q1	$9.12M	Sell	112,500 -112,500	-50%	-$10.1M	0.02%	499
2024 Q4	$20.3M	Buy	+225,000	New	+$21.8M	0.03%	331
2024 Q3	–	Sell	-127,900	Closed	-$11.9M	–	2042
2024 Q2	$11.9M	Buy	127,900 +99,900	+357%	+$8.96M	0.02%	404
2024 Q1	$2.66M	Sell	28,000 -214,500	-88%	-$19.9M	0.01%	828
2023 Q4	$21.7M	Buy	+242,500	New	+$18M	0.06%	265
2023 Q3	–	Sell	-181,600	Closed	-$15.1M	–	1675
2023 Q2	$15.1M	Buy	+181,600	New	+$15.2M	0.04%	261
2022 Q3	–	Sell	-150,000	Closed	-$11.5M	–	1988
2022 Q2	$11.5M	Buy	+150,000	New	+$11.3M	0.04%	290
2022 Q1	–	Sell	-100,000	Closed	-$11.2M	–	2470
2021 Q4	$11.2M	Buy	+100,000	New	+$12.1M	0.03%	432
2016 Q4	–	Sell	-200,000	Closed	-$13.3M	–	1671
2016 Q3	$13.3M	Buy	+200,000	New	+$12.4M	0.04%	234
2015 Q4	–	Sell	-25,000	Closed	-$1.94M	–	2121
2015 Q3	$1.94M	Buy	+25,000	New	+$1.97M	0.01%	600

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nomura Holdings's XBI Position: Q3 2018 in Review

Nomura Holdings sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2018, closing a stake of 3,532 shares — an estimated $336K sold.

Nomura Holdings first reported a position in XBI in Q2 2016 and held it in 5 quarters. The position peaked at $2.98M in Q2 2016. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

Nomura Holdings reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2018 after selling out during the quarter.
Nomura Holdings sold 3,532 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $336K.
Nomura Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 5 quarters.
Nomura Holdings's State Street SPDR S&P Biotech ETF position peaked at $2.98M in Q2 2016.
432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on Nomura Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.